Found 15 matching trials
Facilitation Through Aggrastat By drOpping or Shortening Infusion Line in Patients With ST-segment Elevation Myocardial Infarction Compared to or on Top of PRasugrel Loading dOse PHASE3 This is a single-centre, open-label prospective randomized pharmacodynamic ...
Show More Learn More & Join Trial
Tirofiban for the Prevention of Neurological Deterioration in Acute Ischemic Stroke PHASE2 Currently, dual antiplatelet therapy with aspirin and clopidogrel (with loa...
Show More Location
Xuanwu Hospital, Capital Medical University
Learn More & Join Trial
Aspirin Resistance and Percutaneous Coronary Intervention (PCI) PHASE2 The objective of this study is to evaluate if aggressive antiplatelet thera...
Show More Location
Mount Sinai Medical Center
Learn More & Join Trial
Clinical Trial to Evaluate the Safety of Continuous IV Tirofiban in Acute Ischemic Stroke PHASE1 We will recruit men and non-pregnant women of any ethnic background between...
Show More Location
University of Iowa Hospitals and Clinics
Learn More & Join Trial
Randomized Comparison of Cangrelor, Tirofiban and Prasugrel in Patients With STEMI Referred for Primary PCI. PHASE4 Primary percutaneous coronary intervention (PCI) is the main reperfusion th...
Show More Location
University of Ferrara
Learn More & Join Trial
Induced Suppression of Platelets Activity in Aneurysmal SAH Management (iSPASM) PHASE1 This is a phase 1/2a, randomized, double blind, single-center study compari...
Show More Location
University of Iowa
Learn More & Join Trial
The Effect Of Antiplatelets Therapy On Saphenous Vein Coronary Artery Bypass Graft Patency PHASE3 This protocol is designed to evaluate the effect of antiplatelets (Tirafiba...
Show More Location
Prince Sultan Cardiac Center
Learn More & Join Trial
Study on Tirofiban With Aspirin in the Treatment of Acute Penetrating Artery Territory Infarction PHASE4 Perforating artery territorial infarction (PAI) refers to a single ischemic...
Show More Location
The First Hospital of Fangshan District Beijing
Learn More & Join Trial
Efficacy and Safety of Tirofiban for Patients With BAD (BRANT) PHASE3 Branch atheromatous disease (BAD)-related stroke, characterized by subcorti...
Show More Location
Peking Union Medical College Hospital
Learn More & Join Trial
Prevention of Coronary Slow Flow or No-Reflow During EPCI in Patients With Acute STEMI NA Elective percutaneous coronary intervention (EPCI) is the common treatment ...
Show More Location
Anyang District Hospital
Learn More & Join Trial